DEXTRAN SULFATE DISPOSITION IN THE RAT

被引:13
作者
FOSTER, BC [1 ]
GALLICANO, KD [1 ]
WHITEHOUSE, LW [1 ]
MCGILVERAY, IJ [1 ]
机构
[1] HLTH & WELF CANADA, HLTH PROTECT BRANCH, BUR HUMAN PRESCRIPT DRUGS, OTTAWA K1A 0L2, ONTARIO, CANADA
关键词
AIDS; Dextran sulfate; Disposition; Rat;
D O I
10.1002/bdd.2510110705
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Comparative studies of oral and intravenous administration of tritiated dextran sulfate in rats showed markedly different distribution patterns. Following IV dosing about 50 per cent of the radioactivity was recovered in feces and urine within 24 h. The major portion of the recoverable dose was eliminated in the urine as dextran sulfate within 3 h after administration. In orally treated rats only about 32 per cent of the 3H was recovered in the feces and urine, the major fraction being associated with unabsorbed dextran sulfate in the feces. The remainder of the dose in both treatment groups has apparently distributed throughout the rat body with some accumulation in the liver, kidney and spleen. Consequently, the disposition of about 67 per cent or the oral dose could not be fully accounted for by these excretion routes. However, separation with Sephadex columns showed similarities in the 24 h plasma and urine profiles of the IV and orally dosed rats which suggest that while the oral dose was absorbed as dextran sulfate, it underwent rapid metabolism to small molecular weight products prior to entering the systemic circulation which were then widely distributed within the rat. Copyright © 1990 John Wiley & Sons, Ltd.
引用
收藏
页码:595 / 606
页数:12
相关论文
共 10 条
  • [1] ORAL DEXTRAN SULFATE (UA001) IN THE TREATMENT OF THE ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) AND AIDS-RELATED COMPLEX
    ABRAMS, DI
    KUNO, S
    WONG, R
    JEFFORDS, K
    NASH, M
    MOLAGHAN, JB
    GORTER, R
    UENO, R
    [J]. ANNALS OF INTERNAL MEDICINE, 1989, 110 (03) : 183 - 188
  • [2] DEJONG JGN, 1989, CLIN CHEM, V35, P1472
  • [3] ANTIVIRAL ACTIVITY OF POLYACRYLIC AND POLYMETHACRYLIC ACIDS .2. MODE OF ACTION IN VIVO
    DESOMER, P
    DECLERCQ, E
    BILLIAU, A
    SCHONNE, E
    CLAESEN, M
    [J]. JOURNAL OF VIROLOGY, 1968, 2 (09) : 886 - &
  • [4] CHEMISTRY AND PHARMACOLOGY OF HEPARIN
    EHRLICH, J
    STIVALA, SS
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1973, 62 (04) : 517 - 544
  • [5] INHIBITORY EFFECT OF DEXTRAN SULFATE AND HEPARIN ON THE REPLICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) INVITRO
    ITO, M
    BABA, M
    SATO, A
    PAUWELS, R
    DECLERCQ, E
    SHIGETA, S
    [J]. ANTIVIRAL RESEARCH, 1987, 7 (06) : 361 - 367
  • [6] JAQUES LB, 1979, PHARMACOL REV, V31, P99
  • [7] DEXTRAN SULFATE IS POORLY ABSORBED AFTER ORAL-ADMINISTRATION
    LORENTSEN, KJ
    HENDRIX, CW
    COLLINS, JM
    KORNHAUSER, DM
    PETTY, BG
    KLECKER, RW
    FLEXNER, C
    ECKEL, RH
    LIETMAN, PS
    [J]. ANNALS OF INTERNAL MEDICINE, 1989, 111 (07) : 561 - 566
  • [8] DEXTRAN SULFATE SUPPRESSION OF VIRUSES IN THE HIV FAMILY - INHIBITION OF VIRION BINDING TO CD4+ CELLS
    MITSUYA, H
    LOONEY, DJ
    KUNO, S
    UENO, R
    WONGSTAAL, F
    BRODER, S
    [J]. SCIENCE, 1988, 240 (4852) : 646 - 649
  • [9] UENO R, 1987, LANCET, V2, P796
  • [10] WHITLEY CB, 1989, CLIN CHEM, V35, P374